chemotherapy
-
Roche presents five-year survival outcomes for Tecentriq plus chemotherapy in extensive-stage small cell lung cancer
IMbrella A, an extension of the Phase III IMpower133 study, demonstrates the potential for a durable overall survival benefit with…
Read More » -
CARER collaborates with WHOLELEAF for cancer care services
The collaboration between CARER and Wholeleaf aims to offer an integrated approach to cancer patients, combining services and products to…
Read More » -
Glenmark launches AKYNZEO IV for prevention of chemotherapy-induced nausea and vomiting
AKYNZEO IV, a fixed-dose combination of fosnetupitant (235mg) and palonosetron(0.25mg), will be available as a single-dose, ready-to-dilute IV injection Glenmark…
Read More » -
Apollo Proton Cancer Centre treats Asia’s First Radical Pleurectomy surgery with HITOC on adolescent with Ewing’s Sarcoma
The treatment of radical surgery with HITHOC is the first of its kind in Asia for an adolescent Apollo Proton…
Read More » -
Art of Healing Cancer launches high-dose Vitamin C IVC treatment
IV vitamin C has also enhanced patients’ life quality and reduced chemo-related adverse effects, such as tiredness Art of Healing…
Read More » -
FDA approves drug to reduce bone marrow suppression due to chemotherapy
Cosela may help protect bone marrow cells from damage caused by chemotherapy by inhibiting cyclin-dependent kinase 4/6, a type of…
Read More » -
Chemotherapy drug outperforms remdesivir against coronavirus in lab experiments: Study
The researchers identified four promising drugs, which were then tested against the SARS-CoV-2 virus in lab experiments A chemotherapy medication…
Read More »